Trials / Completed
CompletedNCT04612192
Light Therapy for Chronic Insomnia in General Practice
Light Therapy for Chronic Insomnia in General Practice: a Randomized Double Blind Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
* Sleep disorders, especially insomnia * Attention deficits (or disorders), daytime somnolence and drug dependence * The goal is to evaluate whether light therapy could be used as an efficient alternative treatment with direct application in general practice
Detailed description
Insomnia affects 15 to 20% of the general French adult population and increases with age. General practitioners (GPs) are the first confronted to sleep disorders, especially insomnia. Cognitive-behavioral therapies (CBT) have proven effective, but their implementation in everyday practice is limited, and alternative treatments are still needed. Light not only has a great influence on the sleep-wake cycle and alertness, but also on mood and cognitive functions. The administration time of light condition will be calculated for each individual in a modality that has no impact on the circadian phase. Study will be conduct on an outpatient basis in general practice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active luminette | receive an active light using glasses of 1500 lux (an average of 180 photons/s/cm2, with a maximum wavelenght at 468 nm), 30-minute long light therapy in the morning, in a time period defined by sleep log and chronotype questionnaire, on a 4-week period |
| DEVICE | Placebo luminette | receive a placebo light using glasses (an average of n photons/s/cm2, single- band spectrum with a narrow peak at 660 nm under 50 lux), with the same modality as the experimental group |
Timeline
- Start date
- 2021-04-13
- Primary completion
- 2025-02-12
- Completion
- 2025-02-12
- First posted
- 2020-11-02
- Last updated
- 2025-03-12
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04612192. Inclusion in this directory is not an endorsement.